AI-Based Platform for Automated Uroflowmetry Curve Morphology Classification

Plata M1, Azuero J1, Daza F1, Rojas-Rivillas M1, Garcia V1, Gutierrez A1, Cañar S2, Rodriguez T2, Gomez S2, Giraldo L2

Research Type

Clinical

Abstract Category

Urodynamics

Abstract 557
Open Discussion ePosters
Scientific Open Discussion Session 105
Friday 19th September 2025
13:10 - 13:15 (ePoster Station 3)
Exhibition
Urodynamics Techniques Voiding Dysfunction Urodynamics Equipment
1. Hospital Universitario Fundacion Santa Fe de Bogota, 2. Universidad de los Andes
Presenter
Links

Abstract

Hypothesis / aims of study
Uroflowmetry is a key diagnostic tool for assessing lower urinary tract dysfunction (LUTD), providing non-invasive measurements of urinary flow patterns. The interpretation of the flow-volume curve relies on identifying morphological patterns, with a bell-shaped curve indicating normal flow, while other morphologies may suggest abnormality ​(1,2)​. However, subjective interpretation by clinicians introduces variability. This study aims to develop an AI-based platform for automated classification of uroflowmetry curve morphology.
Study design, materials and methods
This is a secondary analysis of an ongoing observational longitudinal study, presenting preliminary findings. We analyzed 50 uroflowmetry graphs interpreted by a single urologist (25 female, 25 male). Voided volumes ranged from 150 to 500 mL, excluding outliers. Curves were labeled as ‘Continuous’ (bell-shaped) or ‘Non-continuous’ (all other morphologies). 

A platform was developed to automatically classify uroflowmetry curves. Images were processed using computer vision algorithms to extract the curve and convert it into a one-dimensional flow signal. Frequency-based analysis, including Fast Fourier Transform (FFT), extracted 112 features per case, serving as input for a linear machine-learning classifier. Model performance was assessed using a hold-out validation set.
Results
The model achieved a macro-averaged F1-score of 75% in distinguishing continuous from non-continuous uroflow curves. This metric combines model precision and recall into a single value, where 100% represents perfect classification. The most relevant information was identified in the low-frequency band (0.02–0.13 Hz), which refers to the slower, broader patterns in the flow signal—essentially, the overall shape and rhythm of the curve rather than rapid, tiny fluctuations. These slower patterns were critical for accurate classification, as they capture the key characteristics that define whether a flow is continuous or non-continuous. Figure 1 illustrates an example output, including the extracted flow signal and the annotated frequency spectrum highlighting the most predictive features.
Interpretation of results
Findings indicate that low-frequency components (0.02–0.13 Hz) are crucial for identifying non-continuous flow-volume morphologies. The model provides an interpretable and objective tool for uroflowmetry analysis, reducing diagnostic variability and enhancing clinical decision support.
Concluding message
This AI-driven approach improves uroflowmetry interpretation by reducing variability and offering quantitative insights into flow-volume alterations. Limitations include selection bias, reliance on a single urologist, and a small sample size. Future studies should incorporate prospective data and additional uroflowmetry parameters (e.g., maximum flow rate; Qmax) to develop a complete machine-learning-based assessment of uroflowmetry.
Figure 1 Model output showing the extracted signal using computer vision (left column) and key components used for uroflowmetry classification (right column).
References
  1. View of Age, gender, and voided volume dependency of peak urinary flow rate and uroflowmetry nomogram in a tertiary care centre [Internet]. [cited 2025 Mar 31]. Available from: https://www.apjhs.com/index.php/apjhs/article/view/7/901
  2. Gammie A, Clarkson B, Constantinou C, Damaser M, Drinnan M, Geleijnse G, et al. International continence society guidelines on urodynamic equipment performance. Neurourol Urodyn [Internet]. 2014 Apr 1 [cited 2025 Mar 31];33(4):370–9. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/nau.22546?
Disclosures
Funding None Clinical Trial No Subjects Human Ethics Committee Corporate Research Ethics Committee, Hospital Universitario Fundacion Santa Fe de Bogota Helsinki Yes Informed Consent Yes
15/07/2025 06:31:22